Form 4 for AORT ARTIVION, INC.
Accepted 2025-11-18 00:00:00 ET · period of report 2025-11-14 · accession 0001628280-25-052820 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-18 | 2025-11-14+ | AORT | Davis John E | Chief Commercial Off | S - Sale+OE | $44.92 | -12.8K | 198.8K | -6% | -$574.4K |
| DM | 2025-11-18 | 2025-11-14+ | AORT | Davis John E | Chief Commercial Off | M - OptEx | $29.62 | +12.8K | 205.2K | +7% | +$378.8K |
| DM | 2025-11-18 | 2025-11-14+ | AORT | Davis John E | Chief Commercial Off | M - OptEx | $0.00 | -12.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-17 | S | D | 6,394 | $45.17 | 198,842 | D | — | — | (F1) The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025. |
| 2 | Common | Common Stock | 2025-11-17 | M | A | 6,394 | $29.62 | 205,236 | D | — | — | (F1) The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025. |
| 3 | Common | Common Stock | 2025-11-14 | S | D | 6,393 | $44.67 | 198,842 | D | — | — | (F1) The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025. |
| 4 | Common | Common Stock | 2025-11-14 | M | A | 6,393 | $29.62 | 205,235 | D | — | — | (F1) The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025. |
| 5 | Derivative | Stock Options (Right to buy) | 2025-11-17 | M | D | 6,394 | $0.00 | 0 | D | $29.62 · 2020-03-05 to 2026-03-05 | 6,394 Common Stock | (F1) The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025. (F2) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020. |
| 6 | Derivative | Stock Options (Right to buy) | 2025-11-14 | M | D | 6,393 | $0.00 | 0 | D | $29.62 · 2020-03-05 to 2026-03-05 | 6,393 Common Stock | (F1) The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025. (F2) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020. |